SYB symbion health limited

novartis sniffing around mayne

  1. nomcondo
    865 Posts.
    clock Created with Sketch.
    26/07/05
    07:45
    Post #: 1050996
    Would not surprise Novartis checks out Mayne for its injectible business,Teva wanted it a few yrs ago and now they have their hands full-would not surprise Mayne gets snapped up,see what happens today-I expect a jump
    SYB Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

ATC Altech taps investors for $3.7M as EU lithium plans evolve into shape
right-arrow Created with Sketch.
FHE Frontier Energy outlines ESG credentials in latest sustainability report
right-arrow Created with Sketch.
RDN Raiden ready to drill, with final heritage work ticked off at Andover North
right-arrow Created with Sketch.
FHE Frontier Energy targets credit approved terms for Waroona by July
right-arrow Created with Sketch.
EGR EcoGraf jumps as AngloGold Ashanti farms into non-core asset for $14M gold hunt
right-arrow Created with Sketch.
HAR Haranga shores up confidence in Sanela as data points to potential
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add SYB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.